# Momenta Pharmaceuticals

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/momenta-pharmaceuticals

- Industry: Biotechnology
- Headquarters: Cambridge, US
- Website: www.momentapharma.com
- Total disclosed funding: $40M
- Latest round: Series C (Feb 27, 2004)
- Investors on record: 4

## About

Founded in 2001 and based in Massachusetts, US, Momenta Pharmaceuticals, Inc., formerly known as Mimeon Inc., operates as a biotechnology company that focuses on the characterization and engineering of Neurology and Hematology therapeutics to treat patients with rare immune-mediated disease.

## Funding rounds

- Series C, Feb 27, 2004, $21M — Atlas Venture, Cardinal Partners, MVM Partners, Polaris Partners
- Series B, May 21, 2003, $19M — Atlas Venture, Cardinal Partners, MVM Partners, Polaris Partners
- Series A, Jun 1, 2001 — Cardinal Partners, Polaris Partners

## Investors

- Cardinal Partners (https://capitalatlas.ai/funds/cardinal-partners) — Series A, Series B, Series C
- Polaris Partners (https://capitalatlas.ai/funds/polaris-partners) — Series A, Series B, Series C
- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series B, Series C
- MVM Partners (https://capitalatlas.ai/funds/mvm-partners) — Series B, Series C